back to explore
Johnson & Johnson logo

JNJ

Johnson & Johnson
NEW YORK STOCK EXCHANGE, INC.· Pharmaceuticals· US· IPO 1944-09-25
$263.04
+9.06 (+3.57%)
last quote
Want the full multi-source brief on JNJ?
The agent pulls regulatory filings, news flow, prediction-market pricing, macro context, and aviation OSINT — then synthesizes what's not yet in the price.
open in agent
Today
Open
$255.78
High
$263.10
Low
$254.00
Previous close
$253.98
Fundamentals
Market cap
$626.69B
P/E (TTM)
29.79x
P/S (TTM)
6.50x
P/B
6.13x
Gross margin
67.95%
Operating margin
25.88%
Net margin
21.83%
Rev growth (YoY)
7.87%
EPS growth (YoY)
-3.89%
ROE
26.26%
52W high
$263.10
52W low
$154.21
Beta
0.23x
Upcoming earnings
next 30 days
2026-07-15in 11 days
Q2 2026EPS est $2.87Rev est $25240.4M
Recent news
2026-06-26 → 2026-07-03
Yahoo · 12h
Sector Update: Healthcare Stocks Gain Late Afternoon
Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index and the State
ChartMill · 13h
Which dow jones stocks are moving on Thursday?
Join us in exploring the top gainers and losers within the dow jones index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
Yahoo · 14h
Can Yutrepia Maintain Momentum for LQDA Stock in 2026?
LQDA's Yutrepia launch is gaining traction, with $130 million in Q1 sales, rising prescriptions and profitability as the company expands in PAH.
Yahoo · 14h
Sector Update: Healthcare Stocks Gain Thursday Afternoon
Healthcare stocks were higher Thursday afternoon, with the NYSE Healthcare Index rising 2% and the S
Yahoo · 14h
What Could Push BSX Stock Higher From Here?
While a guidance cut has reset expectations, several core Boston Scientific franchises are accelerating. The Neuromodulation and Interventional Oncology businesses both posted organic sales growth of 15% last quarter. This internal momentum in high-value categories contrasts sharply with the new, more cautious company-wide outlook.
Yahoo · 14h
This ‘Dividend’ ETF Pays Just 1.2% | So Why Do Serious Investors Keep Buying It?
The WisdomTree U.S. Quality Dividend Growth Fund (NASDAQ:DGRW) pays a trailing yield of roughly 1.28%, which sounds thin for something with “Dividend” in its name and downright embarrassing next to the 3%-plus yields on traditional income ETFs. And yet DGRW keeps pulling in serious institutional capital. PNC, Bank of America, and Ameriprise all lifted their ... This ‘Dividend’ ETF Pays Just 1.2% |
Yahoo · 14h
JNJ Stock Management Sees A Breakout, The Market Sees A Standoff
The healthcare giant raised its outlook for the year, yet the market is holding back its reward, creating a tense waiting game for investors.
Yahoo · 15h
The Portfolio That Could Put You in a New Car Every Year for Life
The average new vehicle in the United States now costs roughly $49,000, with full-size pickups and many luxury models pushing far higher. That puts a quietly absurd idea within reach for people who think in terms of dividend income: building a portfolio that throws off enough cash every year to buy a new car without ... The Portfolio That Could Put You in a New Car Every Year for Life
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial